142 related articles for article (PubMed ID: 7844523)
1. Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene.
Busson P; Edwards RH; Tursz T; Raab-Traub N
J Gen Virol; 1995 Jan; 76 ( Pt 1)():139-45. PubMed ID: 7844523
[TBL] [Abstract][Full Text] [Related]
2. Sequence variation in the Epstein-Barr virus latent membrane protein 1.
Miller WE; Edwards RH; Walling DM; Raab-Traub N
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2729-40. PubMed ID: 7931159
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus types 1 and 2 have nearly identical LMP-1 transforming genes.
Sample J; Kieff EF; Kieff ED
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2741-6. PubMed ID: 7931160
[TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases.
Ikeda M; Ikeda A; Longan LC; Longnecker R
Virology; 2000 Mar; 268(1):178-91. PubMed ID: 10683340
[TBL] [Abstract][Full Text] [Related]
5. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
Sjöblom A; Nerstedt A; Jansson A; Rymo L
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
[TBL] [Abstract][Full Text] [Related]
6. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population.
Chen ML; Tsai CN; Liang CL; Shu CH; Huang CR; Sulitzeanu D; Liu ST; Chang YS
Oncogene; 1992 Nov; 7(11):2131-40. PubMed ID: 1331932
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency.
Fruehling S; Swart R; Dolwick KM; Kremmer E; Longnecker R
J Virol; 1998 Oct; 72(10):7796-806. PubMed ID: 9733815
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.
Fielding CA; Sandvej K; Mehl A; Brennan P; Jones M; Rowe M
J Virol; 2001 Oct; 75(19):9129-41. PubMed ID: 11533177
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
Allday MJ; Crawford DH; Thomas JA
J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
[TBL] [Abstract][Full Text] [Related]
10. The molecular epidemiology and evolution of Epstein-Barr virus: sequence variation and genetic recombination in the latent membrane protein-1 gene.
Walling DM; Shebib N; Weaver SC; Nichols CM; Flaitz CM; Webster-Cyriaque J
J Infect Dis; 1999 Apr; 179(4):763-74. PubMed ID: 10068570
[TBL] [Abstract][Full Text] [Related]
11. Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction.
Swart R; Fruehling S; Longnecker R
Virology; 1999 Oct; 263(2):485-95. PubMed ID: 10544120
[TBL] [Abstract][Full Text] [Related]
12. Sequence variations between two Epstein-Barr virus LMP 1 variants have no effect on the activation of NF-kappaB activity.
Yeh TS; Li SN; Wu CJ; Liu ST; Meng CL; Chang YS
DNA Cell Biol; 1997 Nov; 16(11):1311-9. PubMed ID: 9407003
[TBL] [Abstract][Full Text] [Related]
13. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
[TBL] [Abstract][Full Text] [Related]
14. Coupled transcription of Epstein-Barr virus latent membrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinomas.
Chen F; Hu LF; Ernberg I; Klein G; Winberg G
J Gen Virol; 1995 Jan; 76 ( Pt 1)():131-8. PubMed ID: 7844522
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation.
Dawson CW; Rickinson AB; Young LS
Nature; 1990 Apr; 344(6268):777-80. PubMed ID: 2158628
[TBL] [Abstract][Full Text] [Related]
16. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines.
Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR
J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
Laux G; Dugrillon F; Eckert C; Adam B; Zimber-Strobl U; Bornkamm GW
J Virol; 1994 Nov; 68(11):6947-58. PubMed ID: 7933076
[TBL] [Abstract][Full Text] [Related]
18. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
Kis LL; Takahara M; Nagy N; Klein G; Klein E
Immunol Lett; 2006 Apr; 104(1-2):83-8. PubMed ID: 16386314
[TBL] [Abstract][Full Text] [Related]
19. Unexpected absence of the Epstein-Barr virus (EBV) lyLMP-1 open reading frame in tumor virus isolates: lack of correlation between Met129 status and EBV strain identity.
Erickson KD; Berger C; Coffin WF; Schiff E; Walling DM; Martin JM
J Virol; 2003 Apr; 77(7):4415-22. PubMed ID: 12634399
[TBL] [Abstract][Full Text] [Related]
20. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
Chabay P; De Matteo E; Merediz A; Preciado MV
Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
